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ABSTRACT
The genomic characterization of Suid herpesvirus 1 (SHV-1) isolates from Argentina was accomplished by restriction
pattern analysis using the BamHI, BstEII and XhoI enzymes. Type II genome has been described only once in Argen-
tina. This study revealed considerable homogeneity of BamHI endonuclease sites in all the strains analyzed, accord-
ing to the number and size of the fragments. No deletion of BamHI fragment #7 among the Argentinean isolates
suggests that these strains are wild-type. In addition, the main antigenic domain of glycoprotein E of all the Argentinean
strains, as well as the reference strains and sequences available in the GenBank, were characterized. The similarity
percent oscillated between 99 and 100%.
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RESUMEN
Caracterización de cepas de campo de Herpesvirus suino 1 aisladas en Argentina. Se caracterizaron cepas
argentinas de herpesvirus suino tipo 1 (HVS-1) mediante corte con las enzimas de restricción BamHI, BstEII y XhoI.
La presencia del tipo genómico II había sido reportada en la Argentina una sola vez y, hasta el momento, no se han
informado nuevos casos. Este estudio reveló una homogeneidad de los sitios BamHI, acorde con el número y el
tamaño de los fragmentos. La presencia del fragmento BamHI #7 en los aislamientos argentinos analizados sugiere
que éstos pertenecen al tipo salvaje (wild-type). Además, se caracterizó el principal dominio inmunogénico de la
glicoproteína E de todas las cepas argentinas y se lo comparó con los de las cepas de referencia y con las secuencias
disponibles en la base de datos GenBank. Los porcentajes de similitud obtenidos oscilaron entre 99 y 100%.
Palabras claves: Herpesvirus suino 1, patrones de restricción, glicoproteína E
Aujeszky’s disease (AD) or Pseudorabies (Pr) is one
of the most significant infectious diseases in the pig in-
dustry. The causative agent, Suid herpesvirus 1 (SHV-
1), is indigenous in swine and is probably the cause of
mass mortality among piglets. AD is manifested by vari-
ous degrees of respiratory distress, nervous and genital
disorders, and even mortality, according to the host age
and the virulence of the viral strain involved. Also, after
recovery, a latent infection is established. SHV-1, a mem-
ber of the Alphaherpesvirinae subfamily, is a double-
stranded DNA virus of approximately 90 megadaltons,
composed of long and short unique sequences. The short
sequence is bracketed by the internal and terminal re-
peat sequences (IR and TR respectively) and contains a
group of four glycoprotein genes: gD, gE, gI and gG. This
short sequence is located in the BamHI fragment #7 and
is composed of 6.7 Kbp (10). Glycoprotein E, an enve-
lope glycoprotein consisting of 577 amino acids (1.7 Kbp),
is one of the SHV-1 virus virulence determinants, but is
non-essential for in vitro replication. The main antigenic
domain of gE has been identified between amino acids
52 and 84 (7). Field isolates of SHV-1 have been subdi-
vided into genome types I, II and III, based on restriction
pattern analysis using the BamHI enzyme (6). Thereaf-
ter, a subtyping has been carried out using other restric-
tion enzymes, such as BstEII and XhoI: genome type I
(Ia, Iia, Ib, In, Ip, Is and Iip), genome type II (IIa, IIp) and
genome type III (IIIa and IIIp). RFLP of the SHV-1 ge-
nome has been used to analyze strains isolated in
Argentina since 1994. At that moment, type I and II ge-
nome types of SHV-1 strains were known in Argentina,
although the outbreak of genome type II has occurred
only once so far (2). After that, we isolated five Argentinean
strains from pigs with symptoms compatible with AD, com-
ing from different regions of the country. In 1998, the
Servicio Nacional de Sanidad Animal (SENASA) established
a voluntary vaccination with an inactivated-gE-deleted
vaccine. However, there is no information about the vaccine
strains used in our country, because its importation was
discontinued in 2001. The commercially available gE-
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deleted vaccine strains used worldwide include Bartha,
NIA-3, NIA-4, Bucharest and Begonia strains (http://
www.oie.int/esp/normes/mmanual/A_00041.htm). The
latter is used in the Pr eradication program of Santa
Catarina State in Brazil (13). The purpose of the present
study was to investigate the possible genetic variation
among SHV-1 strains from Argentina by RFLP analysis
in order to know if the strains are vaccine derivatives in
comparison with non-deleted reference strains. In addi-
tion, we analyzed a partial sequence of the gE gene
against the gE sequences available in the GenBank (Ta-
ble 1). This is the first Argentinean study comparing se-
quences of SHV-1 strains.
By using RFLP, we analyzed 13 SHV-1 strains, nine
of which were isolated in Argentina from 1979 to 1998,
and four have been previously characterized (RC/79, Mer,
CL/7 and CL/15) (2). The non-deleted reference strains
used were Ind-S (9), Alf (6) and S-66 (12), classified as
type I, and YS-81, classified as type II (3). The CL/7, CL/
15, TL/92, A/94, CL/96, CL/98 and CLP/98-10 strains were
isolated in our laboratory, while the RC/79 and Mer strains
were isolated in other Argentinean laboratories. All strains
were propagated twice in Continuous Porcine Kidney
(CPK) cell line cultures. The cells were grown in Eagle’s
medium (Gibco Invitrogen Corporation, USA) supple-
mented with 10% heat-inactivated fetal calf serum and
antibiotics (penicillin-streptomycin). DNA was isolated
from the cells infected with each viral strain at a multiplic-
ity of infection between 1 and 5. CPK cells grown in 75
cm3 plastic flasks were inoculated with 1ml of supernatant
of positive cell cultures, and after an extensive cytopathic
effect was observed, pellets were washed and suspended
in TEN buffer consisting of 100 mM Tris-HCl (pH7.5), 12.5
mM EDTA (pH 8.0), 150 mM NaCl and 1% SDS. Protein-
ase K at a final concentration of 0.2 mg/ml was then added
and incubated at 50 °C for 4 h. The lysate was extracted
once with TE buffer (10 mM Tris-HCl pH 8.0 and 1 mM
EDTA pH 8.0), saturated phenol, and once with a mix-
ture of phenol-chloroform-isoamylalcohol (25:24:1). Fi-
nally, total DNA was precipitated with two volumes of 99%
ethanol, rinsed twice with 70% ethanol, dried and dis-
solved in 40 µl of sterilized distilled water. The quantity
and quality of DNA was determined by measuring ab-
sorbance at an OD260/OD280 ratio in a spectrophotometer
SmartSpec 3000 (Bio-Rad, USA). Approximately 1.5 µg
of DNA solution from each viral strain was digested over-
night with 2UI of BamHI at 37 °C, and then separated by
electrophoresis in 0.7% (w/v) agarose gel (140 x 150 x 5
mm) in TAE buffer (40 mM Tris-acetate pH 7.8, 5 mM
sodium acetate, and 1 mM EDTA) at 20 V for 16 h at
room temperature, stained with ethidium bromide, visu-
alized and photographed under a UV illuminator. After
classifying all the strains as genome type I or II according
to the BamHI pattern, the BstEII and XhoI enzymes were
used to establish the subtypes respectively. The diges-
tion reactions were carried out according to the condi-
tions used for BamHI. Lambda DNA cleaved with HindIII
and EcoRI + HindIII were used as size markers.
For Southern blotting (SB) analysis, electrophoretically
separated DNA-fragments (1% w/v agarose) were trans-
ferred to nylon membranes (Hybond N+ membrane,
Amersham, UK) in 20X SSC buffer (3 M sodium chloride,
300 mM sodium citrate, pH 7.0) and then prehybridized
at 42 °C for 4 h in a solution containing 50% formamide,
6X SSC buffer (0.9 M sodium chloride and 0.09 M so-
dium citrate), 5X Denhardt’s solution (0.1% bovine se-
rum albumin -BSA-, 0.1% polyvinylpirrolidone, 0.1%
Ficoll), 0.2% BSA, 1% sodium dodecyl sulfate -SDS-, 10
mM EDTA and 100 µg/ml denatured salmon sperm DNA.
Probe hybridization proceeded overnight at 42 °C with
the biotinylabeled BamHI  fragment #7 originated from
the Ind-S strain (Bio Prime DNA kit labeling system, BRL
Life Technology) in hybridization buffer (40 mM Tris, 1
mM EDTA, 5X Denhardt’s, 6X SSC, 0.1% BSA, 0.1%
SDS). The chromogenic detection streptavidin-alkaline
phosphatase method was used.
To amplify the main antigenic domain of gE (286 bp),
we designed the following primers: ForgEpi (5’-CCC CGA
GCC TCT CCG CCG A-3’) and RevgEpi (5’-TCG CAG
CCG CGG ACG GGC A-3’). PCR was performed in a
DNA Thermal Cycler (Perkin-Elmer Cetus, Norwalk, CT,
USA). A single PCR amplification was carried out accord-
ing to the manufacturer’s protocols using PCR Master
Mix (Promega). Denaturation, annealing and extension
consisted of 30 cycles at 94 °C for 30 s, 60 °C for 45 s
and 72 °C for 1 min, respectively. PCR products were
analyzed on 2.5% (w/v) agarose gels in TAE buffer, and
stained with ethidium bromide. The products were visu-
alized under UV light. The PCR products were purified
according to the manufacturer’s protocols using Wizard
SV Gel and PCR Clean-Up System (Promega). PCR prod-
ucts were cloned into a pGEM-T Easy plasmid (Promega).
After transformation of E. coli JM109 strain, the plasmid
DNA was extracted and purified by the Wizard Plus
Table 1. Viral isolates from GenBank
Strain Country Accession number
Fa China AF403049
Min-A China AY170318
LA China AY173124
PRV-SH China AF207700
Becker Europe AY368490
Rice USA M14336
Yangsan South Korea AY249861
Guangdong China AF403050
RongA China AY683134
Ea China AF171937
GDSH China EF552427
P-PrV Malaysia FJ176390.1
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Miniprep DNA Purification System (Promega). Two colo-
nies of each strain were analyzed. Both chains of each
cloned strain were sequenced using M13 standard prim-
ers by Mega BACETM 1000 (IGEVET, FCV-UNLP, La
Plata, Argentina). Twelve sequences from different geo-
graphical origins were downloaded from the GenBank and
were included in this analysis (Table 1). The sequence
alignments and edition were carried out using the ClustalX
version 1.92 (15) and BioEdit software version 5 (5). The
percentage of similarity between sequences was calcu-
lated using the similarity index implemented in PAUP
software (14).
According to the classification based on the presence
of fragment 2 using BamHI (6), all Argentinean strains,
except for the Mer strain, were classified into genome
type I. Although the Mer strain (which is classified as type
II) has only been isolated once so far, the five strains
isolated after 1994 are still classified as type I. In the typi-
cal pattern II, an extra BamHI cleavage site, named 2a
and 2b, appeared in fragment 2. Regarding type I, there
were no alterations involving the gain or loss of BamHI
cleavage sites in any of the strains analyzed. Although
all Argentinean type I strains presented almost the same
pattern, there were small differences and the main varia-
tion was in the 5+14’, 10 and 12 fragments. In the
Argentinean strains, as well as in the Alf strain, the 5+14’
fragment was smaller than in the Ind-S and S-66 strains.
Fragment 10 of strains RC/79 and CL/96 shifted its mi-
gration to the position of fragment 9; also fragment 10
presented different mobility from that of the others. In
addition, fragment 12 was very variable in size in all the
strains analyzed. In the subtyping analysis, BstEII was
used to identify two subtypes: Is and Ip. Strains RC/79,
CL/7, CL/15, TL/92, A/94 and CL/96 were classified as
Is, because they showed an additional cleavage site in
the BstEII fragment 2. In contrast, strains CL/98 and CLP/
98-10 were classified as Ip. Taking into account BamHI
and BstEII patterns, the Ind-S strain was classified into
subtype Iia because its restriction pattern presented an
additional cleavage site in fragment 5. Since the pattern
of the S-66 strain was characterized by the lack of BamHI
cleavage sites between fragments 14’ and 5’, S-66 was
classified as subtype Iip. In addition, the Alf strain was
classified as subtype Ib because its pattern showed an
enlarged fragment 11 that co-migrated with fragment 10.
Mer and YS-81 strains were verified as genome type II,
subtype IIp. The restriction analysis using XhoI did not
show different patterns between these two strains (Fig-
ure 1 and Table 2). When we analyzed the results ob-
tained by SB analysis, we detected that fragment BamHI
#7 of all strains, even type I or II, was in the same posi-
tion and thus, not truncated.
The percentage of similarity between gE nucleotide
sequences of type I Argentinean strains and reference
sequences Rice, Becker, S-66, Ind-S, Alf, Min-A and Ea
was 100%. Besides, type I Argentinean strains showed
99.95% similarity with Fa, LA, Yangsan, Guangdong,
RongA, GDSH and P-PrV strains. All Argentinean strains
showed the lowest percentage of similarity (99.3%) with
the PRV-SH strain. Likewise, type II Mer strain showed
100% similarity with its reference strain YS-81.
It is clear that all Argentinean SHV-1 strains are BamHI
DNA pattern type I. The only strain isolated in Argentina
previously classified as type II was isolated from animals
imported from Holland (2) and was not disseminated in
our country because all animals had been sacrificed. It
has been reported that genomic type II is common in
Figure 1. Restriction fragments obtained with the BamHI (upper),
BstEII (lower left) and XhoI (lower right) enzymes. Lane 1: strain
RC/79; Lane 2: strain CL/7; Lane 3: strain CL/15; Lane 4: strain
TL/92; Lane 5: strain A/94; Lane 6: strain CL/96; Lane 7: strain
CL/98; Lane 8: strain CLP/98-10; Lane 9: strain S-66; Lane 10:
strain Ind-S; Lane 11: strain Alf; Lane 12: strain Mer; Lane 13:
strain YS-81. Lane M, Lambda DNA cleaved with HindIII; Lane
Ma, Lambda DNA cleaved with EcoRI + HindIII (size expressed
in Kbp). Fragments are numbered following Herrmann et al. (13)
for BamHI patterns type I (left numbers) and type II (right
numbers). Fragments are numbered according to Christensen
(1) for BstEII patterns (left numbers). Arrows indicated differences.
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Holland (4) and that it is the predominant type in the pig
population in Brazil (11, 13).  The restriction patterns us-
ing BamHI were the same as those obtained by others
for reference strains S-66, YS-81 and Ind-S (1, 8, 9), indi-
cating that the passage in cell cultures made in our labo-
ratory did not modify viral DNA. In agreement with the
data obtained by others (4), the most variable BamHI frag-
ments are 5 and 13, which are located within the repeat
regions, and considerable variations can be seen in the
sizes of BamHI fragments, 10, 12 and 8’, which span the
repeat-unique joint regions. In this study, the most vari-
able fragments in Argentinean strains were 5+14’, 10 and
12. No great variations were obtained between the other
fragments. Those variations are known from viruses iso-
lated from the same geographic area and are character-
ized by a different mobility. The Argentinean type I strains
had a high degree of BamHI pattern identity to Alf and
Ind-S strains, especially in fragment 5+14’. It is well known
that the most noticeable change in the vaccine strain pro-
file is the absence of BamHI fragment #7 (10). As re-
ported by Schaeffer et al. (13), the vaccine strains NIA-4,
Bartha, and Begonia could be grouped as type I, although
they are significantly different in their DNA pattern be-
cause they have a deletion in this fragment. Even though
this fragment is transcriptionally very active, it appears to
be conserved and invariable in size among the high vari-
ety of field strains, as previously corroborated by others
(1, 4). No deletion of BamHI fragment #7 was observed
among the Argentinean strains, indicating that they are
wild-type viruses. The differences in fragment position
are relevant since they allow the follow-up of viral spread
within the porcine population and the possible identifica-
tion of vaccine strains. In reference to subtyping, six
Table 2: Viral strains used in this work
Strain Origin (City-State-Country) Characteristic Year Genotype Subtype
of isolation
RC/79 Río Cuarto, Córdoba, Argentina Isolate 1979 Type I Is
Mer Villa Mercedes, San Luis, Argentina Isolate 1981 Type II IIp
CL/7 Chañar Ladeado, Santa Fe, Argentina Isolate 1988 Type I Is
CL/15 Chañar Ladeado, Santa Fe, Argentina Isolate 1988 Type I Is
TL/92 Trenque Lauquen, Buenos Aires, Argentina Isolate 1992 Type I Is
A/94 Arribeños, Buenos Aires, Argentina Isolate 1994 Type I Is
CL/96 Chañar Ladeado, Santa Fe, Argentina Isolate 1996 Type I Is
CL/98 Chañar Ladeado, Santa Fe, Argentina Isolate 1998 Type I Ip
CLP/98-10 Chañar Ladeado, Santa Fe, Argentina Isolate 1998 Type I Ip
Ind-S Indiana, United States Reference strain 1962 Type I Iia
S-66 Sweden Reference strain 1966 Type I Iip
YS-81 Tsukuba, Yamagata, Japan Reference strain 1981 Type II IIp
Alf Alfort, France Reference strain Nd Type I Ib
Nd. Not determined
strains (RC/79, CL/7, CL/15, TL/92, A/94, CL/96) were
classified as subtype Is and two (CL/98, CLP/98-10) as
subtype Ip, whereas the Mer strain was classified as IIp.
This study revealed the absence of type In and type III in
Argentina. When we analyzed the sequence of the frag-
ment encoding the main antigenic domain of the gE pro-
tein, we found that the differences between the genome
type I and type II strains are not significant. Due to the
high similarity detected between analyzed sequences,
future studies aiming to carry out a phylogenetic analysis
of SHV-1 strains from Argentina, will benefit from choos-
ing other more variable regions. In summary, the
Argentinean viruses were wild type and were classified
as type I, suggesting that no major variation has occurred
in SHV-1 spreading in Argentina since the first outbreak
was noticed. No new isolates belonging to genome type
II have been reported since 1981.
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